A detailed history of Rock Springs Capital Management LP transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Rock Springs Capital Management LP holds 605,013 shares of DVAX stock, worth $7.73 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
605,013
Previous 1,292,637 53.2%
Holding current value
$7.73 Million
Previous $14.5 Million 53.58%
% of portfolio
0.23%
Previous 0.45%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.05 - $11.61 $6.91 Million - $7.98 Million
-687,624 Reduced 53.2%
605,013 $6.74 Million
Q2 2024

Aug 14, 2024

SELL
$10.73 - $12.58 $4.11 Million - $4.82 Million
-382,837 Reduced 22.85%
1,292,637 $14.5 Million
Q4 2023

Feb 14, 2024

SELL
$13.09 - $14.98 $1.81 Million - $2.07 Million
-138,284 Reduced 7.62%
1,675,474 $23.4 Million
Q4 2022

Feb 14, 2023

BUY
$10.27 - $13.29 $1.34 Million - $1.73 Million
130,400 Added 7.75%
1,813,758 $19.3 Million
Q3 2022

Nov 14, 2022

BUY
$9.93 - $17.44 $18,867 - $33,136
1,900 Added 0.11%
1,683,358 $17.6 Million
Q2 2022

Aug 15, 2022

BUY
$7.45 - $12.83 $674,701 - $1.16 Million
90,564 Added 5.69%
1,681,458 $21.2 Million
Q1 2022

May 16, 2022

BUY
$9.75 - $14.44 $136,500 - $202,160
14,000 Added 0.89%
1,590,894 $17.2 Million
Q4 2021

Feb 14, 2022

BUY
$13.17 - $20.94 $1.94 Million - $3.08 Million
146,973 Added 10.28%
1,576,894 $22.2 Million
Q3 2021

Nov 15, 2021

SELL
$9.16 - $19.83 $2.29 Million - $4.96 Million
-250,000 Reduced 14.88%
1,429,921 $27.5 Million
Q2 2021

Aug 16, 2021

BUY
$7.25 - $10.99 $155,157 - $235,196
21,401 Added 1.29%
1,679,921 $16.5 Million
Q1 2021

May 17, 2021

BUY
$4.57 - $11.18 $41,587 - $101,738
9,100 Added 0.55%
1,658,520 $16.3 Million
Q4 2020

Feb 16, 2021

BUY
$3.73 - $5.6 $5,595 - $8,400
1,500 Added 0.09%
1,649,420 $7.34 Million
Q3 2020

Nov 16, 2020

SELL
$4.32 - $11.7 $52,704 - $142,740
-12,200 Reduced 0.73%
1,647,920 $7.12 Million
Q2 2020

Aug 14, 2020

BUY
$2.94 - $9.1 $250,252 - $774,592
85,120 Added 5.4%
1,660,120 $14.7 Million
Q4 2019

Feb 14, 2020

SELL
$3.46 - $6.93 $951,500 - $1.91 Million
-275,000 Reduced 14.86%
1,575,000 $9.01 Million
Q3 2019

Nov 14, 2019

BUY
$2.69 - $4.85 $3.23 Million - $5.82 Million
1,200,000 Added 184.62%
1,850,000 $6.61 Million
Q2 2019

Aug 14, 2019

BUY
$3.65 - $7.89 $985,500 - $2.13 Million
270,000 Added 71.05%
650,000 $2.59 Million
Q4 2018

Feb 14, 2019

BUY
$8.14 - $13.28 $911,680 - $1.49 Million
112,000 Added 41.79%
380,000 $3.48 Million
Q2 2018

Aug 14, 2018

BUY
$15.15 - $20.75 $257,550 - $352,750
17,000 Added 6.77%
268,000 $4.09 Million
Q1 2018

May 15, 2018

BUY
$14.65 - $19.9 $1.11 Million - $1.51 Million
76,000 Added 43.43%
251,000 $4.98 Million
Q4 2017

Feb 14, 2018

BUY
$17.3 - $24.08 $173,000 - $240,799
10,000 Added 6.06%
175,000 $3.27 Million
Q3 2017

Nov 14, 2017

BUY
$15.2 - $21.5 $2.51 Million - $3.55 Million
165,000
165,000 $3.55 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.62B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.